GMI, an Immunomodulatory Protein from Ganoderma microsporum, Potentiates Cisplatin-Induced Apoptosis via Autophagy in Lung Cancer Cells.

MLA

Hsin, I.Lun, et al. “GMI, an Immunomodulatory Protein from Ganoderma Microsporum, Potentiates Cisplatin-Induced Apoptosis via Autophagy in Lung Cancer Cells.” Molecular Pharmaceutics, vol. 12, no. 5, May 2015, pp. 1534–43. EBSCOhost, https://doi.org/10.1021/mp500840z.

APA

Hsin, I.-L., Ou, C.-C., Wu, M.-F., Jan, M.-S., Hsiao, Y.-M., Lin, C.-H., & Ko, J.-L. (2015). GMI, an Immunomodulatory Protein from Ganoderma microsporum, Potentiates Cisplatin-Induced Apoptosis via Autophagy in Lung Cancer Cells. Molecular Pharmaceutics, 12(5), 1534–1543. https://doi.org/10.1021/mp500840z

Chicago

Hsin, I-Lun, Chu-Chyn Ou, Ming-Fang Wu, Ming-Shiou Jan, Yi-Min Hsiao, Ching-Hsiung Lin, and Jiunn-Liang Ko. 2015. “GMI, an Immunomodulatory Protein from Ganoderma Microsporum, Potentiates Cisplatin-Induced Apoptosis via Autophagy in Lung Cancer Cells.” Molecular Pharmaceutics 12 (5): 1534–43. doi:10.1021/mp500840z.